Circadia Ventures

Circadia Ventures

Europe; United Kingdom; London United Kingdom; England United Kingdom
Is it you?
Investor info
Type
Venture Capital
Stage focus
  • Seed Round
Industry focus
Description
Circadia Ventures focuses on investments in novel food ingredients, fine chemicals, fuels and next generation materials derived from renewable bio-resources, addressing global trends towards health, wellness and bio-based cleantech. Circadia aims to make equity investments in privately owned companies with strong, defensible technology platforms and management teams whose ambition is to build aggressive high-growth businesses that deliver an exit for investors within three to five years. We target ventures that are able to achieve commercialisation of their first products in large and growing markets within a two-year time-frame. This ‘early to market’ approach sits at the core of our investment strategy. Circadia Ventures is the manager of Tate & Lyle Ventures LP, a £25m venture capital fund backed by Tate & Lyle PLC, one of the world's leading renewable ingredients companies focused on innovation and product development in these sectors. For further details of the fund, please click on the logo opposite.
Relevant investments
  • Company
    Amount
    Round
  • Example example company Inc
    1000000
    Investor meetings
  • Company & Company
    11000000
    Series C funding
  • Example
    524000
    Seed round A
Show more
Connected people
Email visible after logging in
  • Example Example
    Example Exampleexample[email protected]
  • Example Exampleexample
    Example Exampleexample
  • Notexample Examplenot
    Notexample Examplenotexample example[email protected]
  • Example Examplenotexample
    Example Examplenotexampleexample example[email protected]
  • Example Example
    Example Exampleexample[email protected]
  • Example Example
    Example Exampleexample[email protected]
Show more
See other investors focused on
Healthcare
Made with in San Francisco, Berlin, Valencia, Oslo, Cherkasy and Warsaw© 2015-     Foundersuite, Inc.